JARDIANCE® provides triple protection in your patients with CRM conditions:
reduced risk of CV death
or kidney disease progression*1,2
reduced risk of CV death
or hospitalisation for heart failure†3,4
reduced risk of CV death‡5
How important is early diagnosis and intervention when it comes to CKD?
01/04/2024 | Author: Boehringer Ingelheim
Document ID: PC-SG-102385